Evercore ISI analyst Elizabeth Anderson added Omada Health (OMDA) to the firm’s “Tactical Outperform” list as the firm updates estimates and makes several tactical calls in the Healthcare Technology & Distribution group ahead of Q3 earnings season. The firm keeps an Outperform rating and $27 price target on Omada shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMDA:
- Omada Health launches “Meal Map” AI-powered nutrition tool
- Omada Health announces analysis on weight maintenance post GLP-1 discontinuation
- Omada Health initiated with a Neutral at Baird
- Omada Health announce research on cost savings of virtual physical therapy
- Five new option listings and one option delisting on August 22nd